Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan

Satoru Senoo; Kiichiro Ninomiya; Katsuyuki Hotta; Katsuyuki Kiura

doi:10.1007/s10147-019-01424-y

Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan

Satoru Senoo, Kiichiro Ninomiya, Katsuyuki Hotta, Katsuyuki Kiura

Research output: Contribution to journal › Review article › peer-review

2 Citations (Scopus)

Abstract

Squamous cell carcinoma of the lung is associated with smoking in its development and comprises about 20–30% of all lung cancers. Its treatment strategy had been limited for the past decades, inevitably resulting in the poor outcome. However in the 2010s, it has dramatically changed mainly with the recent clinical introduction of immune checkpoint inhibitors. In this review, we will introduce various clinical studies involving squamous cell carcinoma of the lung.

Original language	English
Pages (from-to)	461-467
Number of pages	7
Journal	International Journal of Clinical Oncology
Volume	24
Issue number	5
DOIs	https://doi.org/10.1007/s10147-019-01424-y
Publication status	Published - May 15 2019
Externally published	Yes

Keywords

Cytotoxic drug
Immune checkpoint inhibitor
Squamous cell carcinoma of the lung

ASJC Scopus subject areas

Surgery
Hematology
Oncology

Access to Document

10.1007/s10147-019-01424-y

Fingerprint Dive into the research topics of 'Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan'. Together they form a unique fingerprint.

Cite this

@article{38e49df0be2f40ddb1e6ff13704369f8,

title = "Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan",

abstract = "Squamous cell carcinoma of the lung is associated with smoking in its development and comprises about 20–30% of all lung cancers. Its treatment strategy had been limited for the past decades, inevitably resulting in the poor outcome. However in the 2010s, it has dramatically changed mainly with the recent clinical introduction of immune checkpoint inhibitors. In this review, we will introduce various clinical studies involving squamous cell carcinoma of the lung.",

keywords = "Cytotoxic drug, Immune checkpoint inhibitor, Squamous cell carcinoma of the lung",

author = "Satoru Senoo and Kiichiro Ninomiya and Katsuyuki Hotta and Katsuyuki Kiura",

year = "2019",

month = may,

day = "15",

doi = "10.1007/s10147-019-01424-y",

language = "English",

volume = "24",

pages = "461--467",

journal = "International Journal of Clinical Oncology",

issn = "1341-9625",

publisher = "Springer Japan",

number = "5",

}

TY - JOUR

T1 - Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan

AU - Senoo, Satoru

AU - Ninomiya, Kiichiro

AU - Hotta, Katsuyuki

AU - Kiura, Katsuyuki

PY - 2019/5/15

Y1 - 2019/5/15

N2 - Squamous cell carcinoma of the lung is associated with smoking in its development and comprises about 20–30% of all lung cancers. Its treatment strategy had been limited for the past decades, inevitably resulting in the poor outcome. However in the 2010s, it has dramatically changed mainly with the recent clinical introduction of immune checkpoint inhibitors. In this review, we will introduce various clinical studies involving squamous cell carcinoma of the lung.

AB - Squamous cell carcinoma of the lung is associated with smoking in its development and comprises about 20–30% of all lung cancers. Its treatment strategy had been limited for the past decades, inevitably resulting in the poor outcome. However in the 2010s, it has dramatically changed mainly with the recent clinical introduction of immune checkpoint inhibitors. In this review, we will introduce various clinical studies involving squamous cell carcinoma of the lung.

KW - Cytotoxic drug

KW - Immune checkpoint inhibitor

KW - Squamous cell carcinoma of the lung

UR - http://www.scopus.com/inward/record.url?scp=85062685719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062685719&partnerID=8YFLogxK

U2 - 10.1007/s10147-019-01424-y

DO - 10.1007/s10147-019-01424-y

M3 - Review article

C2 - 30847617

AN - SCOPUS:85062685719

VL - 24

SP - 461

EP - 467

JO - International Journal of Clinical Oncology

JF - International Journal of Clinical Oncology

SN - 1341-9625

IS - 5

ER -